{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:02:51Z","timestamp":1784293371894,"version":"3.55.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Research Fund Project of Jingzhou","award":["2024LHY26"],"award-info":[{"award-number":["2024LHY26"]}]},{"name":"Bethune\u00b7Intelligent Research Supports Public Welfare Development Fund project","award":["2024-YJ-226-J-015"],"award-info":[{"award-number":["2024-YJ-226-J-015"]}]},{"name":"Natural Science Foundation Project of Hubei Province","award":["2026AFC0557"],"award-info":[{"award-number":["2026AFC0557"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52806-y","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:24:37Z","timestamp":1779121477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of GCNT3 as a glycometabolism-associated biomarker in endometrial cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Da","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"issue":"10023","key":"52806_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"P Morice","year":"2016","unstructured":"Morice, P., Leary, A., Creutzberg, C., Abu-Rustum, N. & Darai, E. Endometrial cancer. Lancet (London England). 387 (10023), 1094\u20131108 (2016).","journal-title":"Lancet (London England)"},{"issue":"8","key":"52806_CR2","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay, J. et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer 144(8), 1941\u20131953 (2019).","journal-title":"Int. J. Cancer"},{"key":"52806_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081922","author":"A Markowska","year":"2022","unstructured":"Markowska, A. et al. Endometrial cancer management in young women. Cancers https:\/\/doi.org\/10.3390\/cancers14081922 (2022).","journal-title":"Cancers"},{"issue":"3","key":"52806_CR4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/AOG.0000000000004676","volume":"139","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto, A. N., Broaddus, R. R., Jemal, A. & Siegel, R. L. The changing landscape of gynecologic cancer mortality in the United States. Obstet. Gynecol. 139(3), 440\u2013442 (2022).","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"52806_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman, J. V. Two pathogenetic types of endometrial carcinoma. Gynecol. Oncol. 15 (1), 10\u201317 (1983).","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"52806_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/annonc\/mdx753","volume":"29","author":"SM de Boer","year":"2018","unstructured":"de Boer, S. M. et al. Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer. Ann. Oncol. 29(2), 424\u2013430 (2018).","journal-title":"Ann. Oncol."},{"issue":"2","key":"52806_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/ijgo.14923","volume":"162","author":"JS Berek","year":"2023","unstructured":"Berek, J. S. et al. FIGO staging of endometrial cancer: 2023. Int. J. Gynaecol. Obstet. 162(2), 383\u2013394 (2023).","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"8","key":"52806_CR8","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/s41416-023-02203-3","volume":"128","author":"Y Asami","year":"2023","unstructured":"Asami, Y. et al. Utility of molecular subtypes and genetic alterations for evaluating clinical outcomes in 1029 patients with endometrial cancer. Br. J. Cancer 128(8), 1582\u20131591 (2023).","journal-title":"Br. J. Cancer"},{"issue":"3","key":"52806_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/GCO.0000000000000855","volume":"35","author":"HC Karpel","year":"2023","unstructured":"Karpel, H. C., Slomovitz, B., Coleman, R. L. & Pothuri, B. Treatment options for molecular subtypes of endometrial cancer in 2023. Curr. Opin. Obstet. Gynecol. 35(3), 270\u2013278 (2023).","journal-title":"Curr. Opin. Obstet. Gynecol."},{"issue":"3","key":"52806_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/ijgc-2022-003772","volume":"33","author":"A Leon-Castillo","year":"2023","unstructured":"Leon-Castillo, A. Update in the molecular classification of endometrial carcinoma. Int. J. Gynecol. Cancer. 33 (3), 333\u2013342 (2023).","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"52806_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng, Y., Ley, S. H. & Hu, F. B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 14(2), 88\u201398 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"52806_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1570161117666190405165911","volume":"18","author":"D Lovic","year":"2020","unstructured":"Lovic, D. et al. The growing epidemic of Diabetes Mellitus. Curr. Vasc. Pharmacol. 18(2), 104\u2013109 (2020).","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"10","key":"52806_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","volume":"10","author":"GA Gregory","year":"2022","unstructured":"Gregory, G. A. et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: A modelling study. Lancet Diabetes Endocrinol. 10(10), 741\u2013760 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"52806_CR14","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnz014","author":"IC Lega","year":"2020","unstructured":"Lega, I. C. & Lipscombe, L. L. Review: Diabetes, obesity, and cancer-pathophysiology and clinical implications. Endocr. Rev. https:\/\/doi.org\/10.1210\/endrev\/bnz014 (2020).","journal-title":"Endocr. Rev."},{"issue":"Suppl 2(Suppl 2","key":"52806_CR15","doi-asserted-by":"publisher","first-page":"S233","DOI":"10.2337\/dcS13-2001","volume":"36","author":"EJ Gallagher","year":"2013","unstructured":"Gallagher, E. J. & LeRoith, D. Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer. Diabetes Care 36(Suppl 2(Suppl 2)), S233-239 (2013).","journal-title":"Diabetes Care"},{"issue":"1","key":"52806_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12885-019-5748-4","volume":"19","author":"L Saed","year":"2019","unstructured":"Saed, L. et al. The effect of diabetes on the risk of endometrial cancer: An updated a systematic review and meta-analysis. BMC Cancer 19(1), 527 (2019).","journal-title":"BMC Cancer"},{"issue":"2","key":"52806_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1158\/1055-9965.EPI-06-0751","volume":"16","author":"E Friberg","year":"2007","unstructured":"Friberg, E., Mantzoros, C. S. & Wolk, A. Diabetes and risk of endometrial cancer: A population-based prospective cohort study. Cancer Epidemiol. Biomarkers Prev. 16(2), 276\u2013280 (2007).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"52806_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ygyno.2024.09.007","volume":"190","author":"CA Nief","year":"2024","unstructured":"Nief, C. A. et al. Diabetes mellitus complications associated with recurrence of Stage I endometrioid endometrial cancer: A single-center retrospective study. Gynecol. Oncol. 190, 298\u2013306 (2024).","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"52806_CR19","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1158\/1055-9965.EPI-20-1245","volume":"30","author":"J Pearson-Stuttard","year":"2021","unstructured":"Pearson-Stuttard, J. et al. Type 2 diabetes and cancer: An umbrella review of observational and Mendelian randomization studies. Cancer Epidemiol. Biomarkers Prev. 30(6), 1218\u20131228 (2021).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"34","key":"52806_CR20","doi-asserted-by":"publisher","first-page":"e30299","DOI":"10.1097\/MD.0000000000030299","volume":"101","author":"Y Wang","year":"2022","unstructured":"Wang, Y., Zeng, X., Tan, J., Xu, Y. & Yi, C. Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links. Medicine 101 (34), e30299 (2022).","journal-title":"Medicine"},{"key":"52806_CR21","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.2147\/OTT.S171791","volume":"11","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. Application of weighted gene co-expression network analysis to identify key modules and hub genes in oral squamous cell carcinoma tumorigenesis. OncoTargets Ther. 11, 6001\u20136021 (2018).","journal-title":"OncoTargets Ther."},{"issue":"5","key":"52806_CR22","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s10439-024-03459-3","volume":"52","author":"VA Binson","year":"2024","unstructured":"Binson, V. A. et al. A review of machine learning algorithms for biomedical applications. Ann. Biomed. Eng. 52(5), 1159\u20131183 (2024).","journal-title":"Ann. Biomed. Eng."},{"key":"52806_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23010052","author":"X Lin","year":"2017","unstructured":"Lin, X. et al. Selecting feature subsets based on SVM-RFE and the overlapping ratio with applications in bioinformatics. Molecules https:\/\/doi.org\/10.3390\/molecules23010052 (2017).","journal-title":"Molecules"},{"key":"52806_CR24","unstructured":"B\u00fchlmann, P. Proposing the vote of thanks: Regression shrinkage and selection via the Lasso: a retrospective by Robert Tibshirani. In.; (2010)."},{"key":"52806_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.aca.2020.06.043","volume":"1131","author":"L Blanchet","year":"2020","unstructured":"Blanchet, L. et al. Constructing bi-plots for random forest: Tutorial. Anal. Chim. Acta 1131, 146\u2013155 (2020).","journal-title":"Anal. Chim. Acta"},{"issue":"1","key":"52806_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"52806_CR27","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"52806_CR28","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"52806_CR29","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51(D1), D638-d646 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"52806_CR30","doi-asserted-by":"publisher","first-page":"D1526","DOI":"10.1093\/nar\/gkae1100","volume":"53","author":"C Huang","year":"2025","unstructured":"Huang, C. et al. scCancerExplorer: A comprehensive database for interactively exploring single-cell multi-omics data of human pan-cancer. Nucleic Acids Res. 53(D1), D1526-d1535 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"52806_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta, T. M. et al. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell 173 (2), 338\u2013354e315 (2018).","journal-title":"Cell"},{"issue":"19","key":"52806_CR32","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1158\/0008-5472.CAN-20-1420","volume":"80","author":"J Li","year":"2020","unstructured":"Li, J. & Stanger, B. Z. How tumor cell dedifferentiation drives immune evasion and resistance to immunotherapy. Cancer Res. 80(19), 4037\u20134041 (2020).","journal-title":"Cancer Res."},{"issue":"10","key":"52806_CR33","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1002\/1878-0261.12557","volume":"13","author":"H Lian","year":"2019","unstructured":"Lian, H. et al. Integrative analysis of gene expression and DNA methylation through one-class logistic regression machine learning identifies stemness features in medulloblastoma. Mol. Oncol. 13(10), 2227\u20132245 (2019).","journal-title":"Mol. Oncol."},{"issue":"1","key":"52806_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02696-6","volume":"9","author":"R Ravi","year":"2018","unstructured":"Ravi, R. et al. Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGF\u03b2 enhance the efficacy of cancer immunotherapy. Nat. Commun. 9(1), 741 (2018).","journal-title":"Nat. Commun."},{"issue":"9","key":"52806_CR35","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1016\/j.cell.2024.03.019","volume":"187","author":"S Deng","year":"2024","unstructured":"Deng, S. et al. ITRIPL1 binds CD3\u03b5 to impede T cell activation and enable tumor immune evasion. Cell 187(9), 2305-2323e.e2333 (2024).","journal-title":"Cell"},{"issue":"9","key":"52806_CR36","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-11-3687","volume":"72","author":"A Facciabene","year":"2012","unstructured":"Facciabene, A., Motz, G. T. & Coukos, G. T-regulatory cells: Key players in tumor immune escape and angiogenesis. Cancer Res. 72(9), 2162\u20132171 (2012).","journal-title":"Cancer Res."},{"issue":"10","key":"52806_CR37","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24(10), 1550\u20131558 (2018).","journal-title":"Nat. Med."},{"key":"52806_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","author":"D Maeser","year":"2021","unstructured":"Maeser, D., Gruener, R. F. & Huang, R. S. oncoPredict: An R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief. Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbab260 (2021).","journal-title":"Brief. Bioinform."},{"issue":"Database issue","key":"52806_CR39","first-page":"D955","volume":"41","author":"W Yang","year":"2013","unstructured":"Yang, W. et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41 (Database issue), D955\u2013961 (2013).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"52806_CR40","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F Iorio","year":"2016","unstructured":"Iorio, F. et al. A landscape of pharmacogenomic interactions in cancer. Cell 166(3), 740\u2013754 (2016).","journal-title":"Cell"},{"issue":"8","key":"52806_CR41","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock Vina 1.2.0: New docking methods, expanded force field, and Python bindings. J. Chem. Inf. Model. 61(8), 3891\u20133898 (2021).","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"52806_CR42","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31(2), 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"issue":"7","key":"52806_CR43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9(7), 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"issue":"5","key":"52806_CR44","doi-asserted-by":"publisher","first-page":"e96801","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese, F., Bukhari, A. B., Malhotra, R. & De, A. IHC Profiler: An open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One 9(5), e96801 (2014).","journal-title":"PLoS One"},{"key":"52806_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4733","volume":"5","author":"P Xie","year":"2014","unstructured":"Xie, P. et al. The covalent modifier Nedd8 is critical for the activation of Smurf1 ubiquitin ligase in tumorigenesis. Nat. Commun. 5, 3733 (2014).","journal-title":"Nat. Commun."},{"key":"52806_CR46","doi-asserted-by":"crossref","unstructured":"Dunn, O. J. J. T. Multiple comparisons using rank sums. 6(3):241\u2013252. (1964).","DOI":"10.1080\/00401706.1964.10490181"},{"issue":"5","key":"52806_CR47","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1002\/imt2.238","volume":"3","author":"D Chen","year":"2024","unstructured":"Chen, D. et al. Sangerbox 2: Enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform. iMeta 3 (5), e238 (2024).","journal-title":"iMeta"},{"key":"52806_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/andr.70007","author":"S Yang","year":"2025","unstructured":"Yang, S., Wang, X., Gao, H. & Yuan, S. Motile cilia: Key developmental and functional roles in reproductive systems. Andrology https:\/\/doi.org\/10.1111\/andr.70007 (2025).","journal-title":"Andrology"},{"key":"52806_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cells13231974","author":"D Wloga","year":"2024","unstructured":"Wloga, D., Joachimiak, E., Osinka, A., Ahmadi, S. & Majhi, S. Motile cilia in female and male reproductive tracts and fertility. Cells https:\/\/doi.org\/10.3390\/cells13231974 (2024).","journal-title":"Cells"},{"key":"52806_CR50","doi-asserted-by":"crossref","unstructured":"Groux-Degroote, S. & Delannoy, P. Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy. 22(11):6145. (2021).","DOI":"10.3390\/ijms22116145"},{"issue":"7","key":"52806_CR51","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1097\/IGC.0b013e31825f639f","volume":"22","author":"T Sugiyama","year":"2012","unstructured":"Sugiyama, T. et al. Enhanced expression of sulfatide, a sulfated glycolipid, in well-differentiated endometrial adenocarcinoma. Int. J. Gynecol. Cancer. 22(7), 1192\u20131197 (2012).","journal-title":"Int. J. Gynecol. Cancer."},{"issue":"9","key":"52806_CR52","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1097\/IGC.0b013e31822d2abd","volume":"21","author":"T Lai","year":"2011","unstructured":"Lai, T. et al. Interleukin 17 induces up-regulation of chemokine and cytokine expression via activation of the nuclear factor \u03baB and extracellular signal-regulated kinase 1\/2 pathways in gynecologic cancer cell lines. Int. J. Gynecol. Cancer. 21(9), 1533\u20131539 (2011).","journal-title":"Int. J. Gynecol. Cancer."},{"issue":"15","key":"52806_CR53","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1016\/j.ejca.2010.06.116","volume":"46","author":"C Bilbao","year":"2010","unstructured":"Bilbao, C. et al. Double strand break repair components are frequent targets of microsatellite instability in endometrial cancer. European journal of cancer (Oxford, England\u202f: 1990) 46(15), 2821\u20132827 (2010).","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"key":"52806_CR54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2021.12.031","volume":"529","author":"L Zhan","year":"2022","unstructured":"Zhan, L. et al. LC3 and NLRC5 interaction inhibits NLRC5-mediated MHC class I antigen presentation pathway in endometrial cancer. Cancer Lett. 529, 37\u201352 (2022).","journal-title":"Cancer Lett."},{"issue":"1","key":"52806_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56633-z","volume":"16","author":"N Zhang","year":"2025","unstructured":"Zhang, N. et al. FBXO31-mediated ubiquitination of OGT maintains O-GlcNAcylation homeostasis to restrain endometrial malignancy. Nat. Commun. 16(1), 1274 (2025).","journal-title":"Nat. Commun."},{"issue":"8","key":"52806_CR56","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1158\/1078-0432.CCR-07-4837","volume":"14","author":"L Jia","year":"2008","unstructured":"Jia, L. et al. Endometrial glandular dysplasia with frequent p53 gene mutation: A genetic evidence supporting its precancer nature for endometrial serous carcinoma. Clin. Cancer Res. 14(8), 2263\u20132269 (2008).","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"52806_CR57","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3892\/or.2015.4421","volume":"35","author":"T Takeda","year":"2016","unstructured":"Takeda, T. et al. ARID1A gene mutation in ovarian and endometrial cancers (Review). Oncol. Rep. 35 (2), 607\u2013613 (2016).","journal-title":"Oncol. Rep."},{"key":"52806_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.657326","volume":"12","author":"MV Patel","year":"2021","unstructured":"Patel, M. V. et al. Endometrial cancer suppresses CD8\u2009+\u2009T cell-mediated cytotoxicity in postmenopausal women. Front. Immunol. 12, 657326 (2021).","journal-title":"Front. Immunol."},{"key":"52806_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.788959","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Follicular helper T-cell-based classification of endometrial cancer promotes precise checkpoint immunotherapy and provides prognostic stratification. Front. Immunol. 12, 788959 (2021).","journal-title":"Front. Immunol."},{"issue":"3","key":"52806_CR60","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/14737140.2022.2044311","volume":"22","author":"L Mutlu","year":"2022","unstructured":"Mutlu, L., Harold, J., Tymon-Rosario, J. & Santin, A. D. Immune checkpoint inhibitors for recurrent endometrial cancer. Expert Rev. Anticancer Ther. 22(3), 249\u2013258 (2022).","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"2","key":"52806_CR61","first-page":"200","volume":"6","author":"KS Subramaniam","year":"2016","unstructured":"Subramaniam, K. S. et al. Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6\/STAT-3\/c-Myc pathway. Am. J. Cancer Res. 6(2), 200\u2013213 (2016).","journal-title":"Am. J. Cancer Res."},{"key":"52806_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-015-0231-4","volume":"9","author":"F Teng","year":"2016","unstructured":"Teng, F. et al. Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1\/CXCR4 axis. J. Hematol. Oncol. 9, 8 (2016).","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"52806_CR63","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s43032-019-00009-4","volume":"27","author":"B Burgess","year":"2020","unstructured":"Burgess, B., Levine, B., Taylor, R. N. & Kelly, M. G. Preoperative circulating lymphocyte and monocyte counts correlate with patient outcomes in Type I and Type II endometrial cancer. Reprod. Sci. 27(1), 194\u2013203 (2020).","journal-title":"Reprod. Sci."},{"issue":"34","key":"52806_CR64","doi-asserted-by":"publisher","first-page":"e2315002121","DOI":"10.1073\/pnas.2315002121","volume":"121","author":"O Kovalevskiy","year":"2024","unstructured":"Kovalevskiy, O., Mateos-Garcia, J. & Tunyasuvunakool, K. AlphaFold two years on: Validation and impact. Proc. Natl. Acad. Sci. U.S.A. 121 (34), e2315002121 (2024).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7873","key":"52806_CR65","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596 (7873), 583\u2013589 (2021).","journal-title":"Nature"},{"issue":"2","key":"52806_CR66","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine, Z. E., Schug, Z. T., Salvino, J. M. & Dang, C. V. Targeting cancer metabolism in the era of precision oncology. Nat. Rev. Drug Discovery. 21 (2), 141\u2013162 (2022).","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"5","key":"52806_CR67","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2 (5), e1600200 (2016).","journal-title":"Sci. Adv."},{"key":"52806_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1361419","volume":"14","author":"S Song","year":"2024","unstructured":"Song, S., Zhang, D., Wang, Y. & Song, Z. Changing trends in the disease burden of uterine cancer globally from 1990 to 2019 and its predicted level in 25 years. Front. Oncol. 14, 1361419 (2024).","journal-title":"Front. Oncol."},{"issue":"1","key":"52806_CR69","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA Cancer J Clin 75(1), 10\u201345 (2025).","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"52806_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35731","volume":"131","author":"C Nero","year":"2025","unstructured":"Nero, C. et al. POLE mutations in endometrial carcinoma: Clinical and genomic landscape from a large prospective single-center cohort. Cancer 131(3), e35731 (2025).","journal-title":"Cancer"},{"key":"52806_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1528532","volume":"16","author":"J Huang","year":"2025","unstructured":"Huang, J. et al. Unveiling immunogenic characteristics and neoantigens in endometrial cancer with POLE hotspot mutations for improved immunotherapy. Front. Immunol. 16, 1528532 (2025).","journal-title":"Front. Immunol."},{"key":"52806_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16233918","author":"M Albert\u00ed-Valls","year":"2024","unstructured":"Albert\u00ed-Valls, M., Olave, S., Olom\u00ed, A., Maci\u00e0, A. & Eritja, N. Advances in immunotherapy for endometrial cancer: Insights into MMR status and tumor microenvironment. Cancers https:\/\/doi.org\/10.3390\/cancers16233918 (2024).","journal-title":"Cancers"},{"issue":"11","key":"52806_CR73","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.21037\/tcr-2024-2248","volume":"13","author":"Y Li","year":"2024","unstructured":"Li, Y., Ren, Z., Wu, T., Zhang, N. & He, Z. GCNT3 promotes the proliferation, apoptosis, invasion, and migration of breast cancer through the PI3K\/AKT pathway. Transl. Cancer Res. 13(11), 6381\u20136393 (2024).","journal-title":"Transl. Cancer Res."},{"key":"52806_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-024-10830-5","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Fang, X., Xie, H. & Wang, X. GCNT3 promotes hepatocellular carcinoma progression and EMT by activating the PI3K\/AKT pathway. Biochem. Genet. https:\/\/doi.org\/10.1007\/s10528-024-10830-5 (2024).","journal-title":"Biochem. Genet."},{"issue":"11","key":"52806_CR75","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41416-020-0772-3","volume":"122","author":"R Gupta","year":"2020","unstructured":"Gupta, R. et al. Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. Br. J. Cancer 122(11), 1661\u20131672 (2020).","journal-title":"Br. J. Cancer"},{"issue":"1","key":"52806_CR76","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13048-024-01456-7","volume":"17","author":"C Zhang","year":"2024","unstructured":"Zhang, C., Cui, H., Li, Y. & Chang, X. Predicting CD27 expression and clinical prognosis in serous ovarian cancer using CT-based radiomics. J. Ovarian Res. 17(1), 131 (2024).","journal-title":"J. Ovarian Res."},{"issue":"2","key":"52806_CR77","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1158\/2159-8290.CD-13-0760","volume":"5","author":"NE Reticker-Flynn","year":"2015","unstructured":"Reticker-Flynn, N. E. & Bhatia, S. N. Aberrant glycosylation promotes lung cancer metastasis through adhesion to galectins in the metastatic niche. Cancer Discov. 5(2), 168\u2013181 (2015).","journal-title":"Cancer Discov."},{"issue":"1","key":"52806_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26468-4","volume":"8","author":"LP Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez, L. P. et al. The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance. Sci. Rep. 8(1), 8485 (2018).","journal-title":"Sci. Rep."},{"issue":"9","key":"52806_CR79","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho, S. S. & Reis, C. A. Glycosylation in cancer: Mechanisms and clinical implications. Nat. Rev. Cancer 15(9), 540\u2013555 (2015).","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"52806_CR80","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41419-025-07517-z","volume":"16","author":"T Pienkowski","year":"2025","unstructured":"Pienkowski, T. et al. Leveraging glycosylation for early detection and therapeutic target discovery in pancreatic cancer. Cell Death Dis. 16 (1), 227 (2025).","journal-title":"Cell Death Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52806-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52806-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52806-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:03:13Z","timestamp":1784289793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52806-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52806"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52806-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with national regulations and institutional requirements. The Medical Ethics Committee of Jingzhou First People\u2019s Hospital (reference number: YJ202411) approved the research protocol and granted a waiver of informed consent.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors provided consent for publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22505"}}